A Study to Evaluate Efficacy, Safety & Pharmacokinetics of the Port Delivery System (PDS) With Ranibizumab in Participants With Diabetic Macular Edema (DME) Compared With Intravitreal Ranibizumab; A Substudy to Evaluate the Safety of Re-implanting the PDS With Ranibizumab in Participants With DME
Clinical trial NCT04108156 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT04108156
- Sponsor
- Hoffmann-La Roche
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-09-30
- Primary completion
- 2027-07-20
- Enrollment
- 672
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.